I

Inno-Gene SA
WSE:IGN

Watchlist Manager
Inno-Gene SA
WSE:IGN
Watchlist
Price: 5.04 PLN -0.4% Market Closed
Market Cap: 17.7m PLN
Have any thoughts about
Inno-Gene SA?
Write Note

Inno-Gene SA
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Inno-Gene SA
Total Liabilities Peer Comparison

Comparables:
M
MDB
R
RVU
S
SLV

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
I
Inno-Gene SA
WSE:IGN
Total Liabilities
zł2.7m
CAGR 3-Years
-36%
CAGR 5-Years
-30%
CAGR 10-Years
-14%
M
Medicofarma Biotech SA
WSE:MDB
Total Liabilities
zł3.8m
CAGR 3-Years
82%
CAGR 5-Years
44%
CAGR 10-Years
N/A
R
Ryvu Therapeutics SA
WSE:RVU
Total Liabilities
zł201.2m
CAGR 3-Years
49%
CAGR 5-Years
N/A
CAGR 10-Years
28%
S
Selvita SA
WSE:SLV
Total Liabilities
zł326.7m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Inno-Gene SA's Total Liabilities?
Total Liabilities
2.7m PLN

Based on the financial report for Jun 30, 2024, Inno-Gene SA's Total Liabilities amounts to 2.7m PLN.

What is Inno-Gene SA's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
-14%

Over the last year, the Total Liabilities growth was 43%. The average annual Total Liabilities growth rates for Inno-Gene SA have been -36% over the past three years , -30% over the past five years , and -14% over the past ten years .

Back to Top